Zandy Forbes’ biotech company MeiraGTx has developed targeted gene therapy methods to treat more than just genetic disorders.

A recently launched Phase 1 clinical trial at Mass General Brigham is examining the safety and feasibility of a groundbreaking treatment approach for ...

Early use of continuous positive airway pressure (CPAP) therapy for sleep apnea could help lower Parkinson's risk, a large ...

Read More: A Potential Parkinson’s Treatment Has Promising Results That's because deep brain stimulation and Parkinson’s ...

A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...

A form of Parkinson's disease caused by mutations in a gene known as PINK1 has long been labeled rare. But our research shows ...

More advanced methods may enable better modelling Parkinson’s disease is a considerable health problem owing to its high and rising global prevalence, its progressively degenerative nature, and its ...

The FDA has approved an adaptive deep brain stimulation (aDBS) treatment for people with with Parkinson’s disease, making this groundbreaking technology available to people nationwide.

According to a recent study, obstructive sleep apnea is associated with an increased risk for Parkinson disease.

This article originally appeared in Research Colorado.Research at the University of Denver is showing promise for the ...

This recent study highlights the neuroprotective potential of TFE3, a transcription factor that plays a pivotal role in ...

People with obstructive sleep apnea have an increased risk of Parkinson's disease, but if started early enough, continuous ...